Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Trade receivables and contract assets

v3.24.0.1
Trade receivables and contract assets
12 Months Ended
Dec. 31, 2023
Trade Receivables And Contract Assets [Abstract]  
Trade receivables and contract assets

21. Trade receivables and contract assets

Trade receivables and contract assets are analyzed as follows:

 

 

 

At December 31,

 

 

At December 31,

 

 

 

2023

 

 

2022

 

 

 

(EUR thousand)

 

Trade receivables

 

 

308,425

 

 

 

218,695

 

Allowance for expected credit losses

 

 

(6,656

)

 

 

(5,961

)

Total trade receivables

 

 

301,769

 

 

 

212,734

 

 

 

 

 

 

 

 

 

Trade receivables are non-interest bearing and credit terms are generally 60 to 90 days. The Group is not exposed to significant concentration of third-party credit risk.

Trade receivables breakdown by geographical area is shown below:

 

 

 

At December 31,

 

 

At December 31,

 

 

 

2023

 

 

2022

 

 

 

(EUR thousand)

 

EMEA

 

 

176,638

 

 

 

121,006

 

APAC

 

 

37,574

 

 

 

25,968

 

North America

 

 

79,529

 

 

 

62,287

 

South America

 

 

14,684

 

 

 

9,434

 

Total Trade Receivables

 

 

308,425

 

 

 

218,695

 

 

Trade receivables are stated net of an allowance for expected credit losses which has been determined in accordance with IFRS 9 amounting to EUR 6,656 thousand and EUR 5,961 thousand for 2023 and 2022 respectively:

 

 

 

2023

 

 

2022

 

 

 

(EUR thousand)

 

At January 1

 

 

5,961

 

 

 

6,544

 

Accruals

 

 

1,489

 

 

 

683

 

Releases

 

 

(807

)

 

 

(1,453

)

Utilizations

 

 

(21

)

 

 

(19

)

Exchange differences and other changes

 

 

34

 

 

 

206

 

At December 31

 

 

6,656

 

 

 

5,961

 

Contract assets

Contract assets relate to ongoing customer-specific construction contracts within the Engineering segment and from the In-vitro diagnostic business, which is part of the Biopharmaceutical and Diagnostic Solutions Segment. As such, the balances of this account vary and depend on the number of ongoing construction contracts at the end of the year. The Group had contract assets of EUR 172,580 thousand as at December 31, 2023, and of EUR 103,417 thousand as at December 31, 2022. Contract assets gross amounted to EUR 360,433 thousand (EUR 235,794 thousand as at December 31, 2022), net of advance invoices issued of EUR 187,853 thousand (EUR 132,377 thousand as at December 31, 2022).